| 
			
			 Australia doubles Pfizer order as Astra clotting worries upend 
			rollout 
 Australia has doubled its order of the Pfizer Inc COVID-19 vaccine, 
			Prime Minister Scott Morrison said on Friday, as it raced to 
			overhaul its inoculation plan over concerns about the risks of blood 
			clots with the AstraZeneca Plc vaccine.
 
 Until late Thursday, Australia based its vaccination programme 
			largely on an AstraZeneca shot, with an order for 50 million doses - 
			enough for the required two shots for its entire 25 million 
			population - to be made domestically by biopharma CSL Ltd. But it 
			has now joined a host of countries in restricting use of the vaccine 
			due to clotting concerns.
 
			 
			
 Green, amber or red: UK to classify travel destinations
 
 Britain will confirm in early May whether it will allow 
			international travel to resume from May 17 and which countries will 
			fall into the red, amber or green categories in a new traffic light 
			system based on COVID-19 risks.
 
 Factors in assessing the categories will include the percentage of 
			the population that has been vaccinated, rate of infection, 
			prevalence of variants of concern and the country's access to 
			reliable genomic sequencing.
 
 S.Korea, Japan to tighten curbs
 
 Japan aims to place Tokyo under a new, month-long "quasi-emergency" 
			state to combat surging COVID-19 cases, a minister said on Friday, 
			less than a month after the capital and host of the Summer Olympics 
			lifted a broader state of emergency.
 
 Meanwhile, South Korea will reimpose a ban on nightclubs, karaoke 
			bars and other nightly entertainment facilities from Monday for 
			three weeks, authorities said on Friday, after the number of new 
			coronavirus cases surged, fanning fears over a potential fourth wave 
			of outbreaks.
 
			
            [to top of second column] | 
			
			 French health body to say mRNA 
								vaccine should be used as second dose after 
								AstraZeneca
 France's top health body will on Friday say that 
								recipients of a first dose of AstraZeneca's 
								traditional COVID-19 vaccine who are under 55 
								should get a second shot with a new-style 
								messenger-RNA vaccine, two sources aware of the 
								plans said on Thursday.
 The 
			Haute Autorite de la Sante, in charge of setting out how vaccines 
			approved by the European Medicines Agency should be used in France, 
			has now decided to proceed with the plan, the two sources said. But 
			there is no evidence that this approach combining messenger RNA 
			vaccines with traditional ones such as AsztraZeneca's will be as 
			effective.
 Infections hit record in India
 
 India reported 131,968 new infections on Friday, a record increase 
			for a third straight day, data from the health ministry showed. 
			Deaths rose by 780 to a total of 167,642.
 
 On Thursday, Prime Minister Narendra Modi rejected calls from states 
			to offer vaccines to younger people to help contain the record 
			surge. Inoculations are currently limited to those aged over 45 and 
			health and frontline workers.
 
			 
 (Compiled by Karishma Singh; Editing by Himani Sarkar)
 
			[© 2021 Thomson Reuters. All rights 
				reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content |